Pedro Dorado
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Biological Psychiatry top 5%
Papers in
- Pharmacology 60
- Pharmacogenetics and Drug Metabolism 60
- Inflammatory mediators and NSAID effects 9
- Co-authors
- Adrián LLerenaEva Peñas‐LledóRoland BereczAlfredo de la RubiaMacarena C. CáceresÜmit YaşarJulio LicínioMa‐Li Wong
In The Last Decade
Pedro Dorado
79 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 98
- Pharmacology 1.3k
- Biological Psychiatry 112
- Psychiatry and Mental health 360
- Biochemistry 156
- Pharmacology 340
Countries citing papers authored by Pedro Dorado
This map shows the geographic impact of Pedro Dorado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Dorado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Dorado more than expected).
Fields of papers citing papers by Pedro Dorado
This network shows the impact of papers produced by Pedro Dorado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Dorado. The network helps show where Pedro Dorado may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Dorado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 0 | |
| 9 | 2020 | 0 | |
| 10 | 2020 | 31 | |
| 11 | 2020 | 20 | |
| 12 | 2014 | 7 | |
| 13 | 2013 | 10 | |
| 14 | 2012 | 20 | |
| 15 | 2012 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 2010 | 37 | |
| 18 | 2007 | 29 | |
| 19 | 2002 | 51 | |
| 20 | Stabilization and preservation of hepatic drug metabolizing systems | 1969 | 9 |
About Pedro Dorado
Pedro Dorado is a scholar working on Pharmacology, Biological Psychiatry, Biochemistry, Psychiatry and Mental health and Pharmacology, having authored 83 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (60 papers), Drug Transport and Resistance Mechanisms (18 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Hormonal Regulation and Hypertension (9 papers), Schizophrenia research and treatment (9 papers), Pharmacological Effects and Toxicity Studies (9 papers), Inflammatory mediators and NSAID effects (9 papers) and Epilepsy research and treatment (7 papers). The work is most often cited by research in Pharmacology (1.3k citations), Biological Psychiatry (112 citations), Psychiatry and Mental health (360 citations), Biochemistry (156 citations) and Pharmacology (340 citations). Pedro Dorado has collaborated with scholars based in Spain, Portugal and Mexico. Frequent co-authors include Adrián LLerena, Eva Peñas‐Lledó, Roland Berecz, Alfredo de la Rubia, Macarena C. Cáceres, Ümit Yaşar, Julio Licínio, Ma‐Li Wong, Marja-Liisa Dahl and Gunnel Tybring. Their work appears in journals such as Pharmacogenomics, The Pharmacogenomics Journal, European Journal of Clinical Pharmacology, Pharmaceutics and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.